MLchartDataset catalogue

vicriviroc

Term · Oncology and biomedicine · MLC-T-ONC-017501

A piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. Vicriviroc is designed to bind to CCR5 and inhibit the entry of HIV into CD4 cells.

Table 1. Record
IdentifierMLC-T-ONC-017501
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-017501",
  "term": "vicriviroc",
  "field": "Oncology and biomedicine",
  "definition": "A piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. Vicriviroc is designed to bind to CCR5 and inhibit the entry of HIV into CD4 cells.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/vicriviroc/"
}

Record 17,223 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.